Retatrutide: Why should I buy a weight loss drug that’s still in trial?

Many people are concerned about the latest weight loss product Retatrutide, and some people are already using it to lose weight. However, Retatrutide is still a drug under trials, so why buy it for weight loss?

Weight loss effects of Retatrutide

As a three-receptor agonist, Retatrutide’s weight loss effect was demonstrated in its Phase 2 trial. After 48 weeks of Retatrutide, the average weight loss was 24.2% (57.8 pounds), and the treatment effect was dose-dependent. The effect reducing weight is better than Tirz and Sema.

The three receptors are GLP-1(glucagon-like peptide-1) receptor,GIP(gastric inhibitory peptide) receptor, and GCG(glucagon) receptor.

100% Patients using Reta lost at least 5% of their body weight and 85% patients using Tirz lost at least 5%. This data shows that some users may be ineffective when using Sema or Tirz, and if they use Reta, they will definitely achieve weight loss.

The mechanism of action of GLP-1 and GIP slows down stomach emptying and the rate at which food passes through the digestive system is slower, which means you get full quickly and stay full for longer. In addition to slowing stomach emptying, they also target the hunger center of the brain. The addition of glucagon promotes weight loss in another way. When you’re sleeping or haven’t eaten for hours, your body still needs energy to survive. Without new carbohydrates converted to glucose, the body breaks down stored sugar to provide the energy the body needs. When the body is free of glycogen, GCG shifts our fat stores, breaking down fat for energy. This is why Retatrutide loses weight faster and more than Tirz and Semaglutide.

Why use the weight loss drug Retatrutide in the trial

As mentioned earlier, Retatrutide is more effective for weight loss and is 100% effective if weight loss is not achieved with Tirz and Sema.

There are concerns about its safety. Retatrutide has completed a phase 2 trial and is now in a Phase 3 trial, which is also looking at obese or overweight patients with knee osteoarthritis, type 2 diabetes, cardiovascular disease and other diseases. This is a different trial model than Semaglutide and Tirz, which are both prioritized for the treatment of type 2 diabetes and approved by the FDA for the treatment of type 2 diabetes before weight loss trials. There are a few years between FDA-approved treatment for type 2 diabetes and weight loss. Retatrutide did not prioritise its treatment of type 2 diabetes, but weight loss was carried out alongside diabetes, showing the team’s confidence in it in addition to its better weight loss results.

Am I buy real Retatrutide?

In addition to safety concerns, the availability of real Retatrutide is a key consideration. Some buyers said that the Retatrutide he bought was found to be AOD9604 after testing, while others said that Retatrutide is still in trial and it is not possible to buy real Retatrutide. In fact, once the molecular formula and molecular structure of Retatrutide are determined, you can chemically synthesize the real Reta, and how to synthesize it is really a matter for chemists and laboratories, you just need to test whether the Reta you buy is Retatrutide. If you detect AOD9604, then you are actually deceived, not because the real Reta cannot be synthesized.

Astersteroids provides real Retatrutide, subject to testing, guaranteed quality, welcome to inquire and purchase. If you are still on the fence about Retatrutide, you may choose to continue using Semaglutide or Tirzeptide if they still help you lose weight.